Metabolic imprinting on genetically predisposed neural circuits perpetuates obesity

Nutrition

Volumn 16, Issue 10, 2000, Pages 909-915

  Levin, Barry E ^a,b,c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Diet induced obesity; Hypothalamus; Insulin; Neural development; Neural plasticity; Neuropeptide Y; Obesity therapy

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; DOPAMINE; NEUROPEPTIDE Y;

BODY WEIGHT; BRAIN DEVELOPMENT; CALORIC INTAKE; CONFERENCE PAPER; DIET; ENERGY BALANCE; GENETIC PREDISPOSITION; GENOME IMPRINTING; GLUCOSE METABOLISM; HUMAN; MATERNAL DIABETES MELLITUS; NERVE CELL NETWORK; NERVE CELL PLASTICITY; NONHUMAN; OBESITY; PREGNANCY; PRIORITY JOURNAL;

ANIMAL; DIET; ENERGY METABOLISM; ENVIRONMENT; GENETIC PREDISPOSITION TO DISEASE; HUMAN; NEURAL PATHWAYS; NEURONAL PLASTICITY; OBESITY;

ANIMALIA;

EID: 0033771545     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00408-1     Document Type: Conference Paper

References (137)

1. Is the intra-uterine period really a critical period for the development of adiposity?
2. Hypothalamic control of food intake in rats and cats
3. An arcuato-paraventricular and dorsomedial hypothalamic neuropeptide Y containing system which lacks norepinephrine in the rat
4. Morphological basis of long-term habituation and sensitization in Aplysia
5. Diet-induced insulin resistance precedes other aspects of the metabolic syndrome
6. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus
7. Evidence that the rat arcuate nucleus has two subsets of NPY neurons that are activated by fasting and regulated by insulin and leptin
8. Abnormal characteristics of young offspring of parents with non-insulin-dependent diabetes mellitus. The Bogalusa Heart Study
9. Impaired growth hormone response to insulin-induced hypoglycemia in obese patients; restoration blocked by ritanserin after fenfluramine administration
10. Effects of intracerebroventricular injection of neuropeptide Y on energy metabolism
11. Neuropeptide Y in hypothalamic paraventricular nucleus; a center coordinating energy metabolism
12. Neuroendocrine abnormalities in human obesity
13. Genetics of obesity
14. Genetic influences on the response of body fat and fat distribution to positive and negative energy balances in human identical twins
15. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats
16. Neurochemical organization of the hypothalamic projection of the spinal cord in the rat
17. Metabolic differences between obesity-prone and obesity-resistant rats
18. Skeletal muscle utilization of free fatty acids in women with visceral obesity
19. Energy expenditure in rats with diet-induced obesity
20. Metabolic syndrome in a diet-induced obesity model
21. Abnormally high nourishment during sensitive periods results in body weight changes across generations
22. Further evidence for the dependence of diabetes prevalence on nutrition in perinatal life
23. Perinatal hyperinsulinism as possible predisposing factor for diabetes mellitus, obesity and enhanced cardiovascular risk in later life
24. Vibrissectomy induced changes in GAP-43 immunoreactivity in the adult rat barrel cortex
25. Location and effect of obesity on putative anorectic binding sites in the rat brain
26. + channel in rat brain
27. Low affinity sulfonylurea binding sites reside on neuronal cell bodies in the brain
28. Long-term effects of early nutritional experience on the development of obesity in the rat
29. The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system
30. Monosynaptic connections from the sensory neurons participate in the storage of long-term memory for sensitization of the gill- and siphon-withdrawal reflex in Aplysia
31. Increased cortical representation of hunger and satiation in obese men
32. International trial of long-term dexfenfluramine in obesity
33. Syndrome X-like alterations in adult female rats due to neonatal insulin treatment
34. Overweight and increased diabetes susceptibility in neonatally insulin-treated adult rats
35. Insulin stimulates the activity of a novel protein kinase C, PKC-epsilon, in cultured fetal chick neurons
36. Hypothalamic lesions and adiposity in the rat
37. Lack of diet-induced thermogenesis in brown adipose tissue of obese medial hypothalamic-lesioned rats
38. Central command neurons of the sympathetic nervous system; basis of the fight-or-flight response
39. The effect of diet on food intake and adiposity in rats made obese by gestational undernutrition
40. Obesity and adipocyte abnormalities in offspring of rats undernourished during pregnancy
41. Maternal insulin manipulations in rats organize body weight and noradrenergic innervation of the hypothalamus in gonadally intact male offspring
42. Maternal hormonal manipulations in rats cause obesity and increase medial hypothalamic norepinephrine release in male offspring
43. Gestational undernutrition and the development of obesity in rats
44. Metabolic defense of the body weight set-point
45. Body weight and body composition of male rats following hypothalamic lesions
46. Effect of depletion of brain serotonin by repeated fenfluramine on neurochemical and anorectic effects of acute fenfluramine
47. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960-1991
48. Energy metabolism in weight-stable postobese individuals
49. Neuropeptide Y expression and endogenous leptin concentrations in a dietary model of obesity
50. Growth hormone secretion and synthesis are depressed in obesity-susceptible compared with obesity-resistant rats
51. Neonatal rat dietary carbohydrate affects pancreatic islet insulin secretion in adults and progeny
52. Sibutramine-a review of clinical efficacy
53. Diminished energy requirements in reduced-obese patients
54. Changes in energy expenditure resulting from altered body weight
55. 3H paraminoclonidine binding
56. Defective cerebral glucose utilization in diet-induced obese rats
57. Glucose increases rat plasma norepinephrine levels by direct action on the brain
58. Intracarotid glucose-induced norepinephrine response and the development of diet-induced obesity
59. Sympathetic activity, age, sucrose preference and diet-induced obesity
60. Diet cycling and age alter weight gain and insulin levels in rats
61. Reduced norepinephrine turnover in organs and brains of obesity-prone rats
62. Reduced paraventricular nucleus norepinephrine responsiveness in obesity-prone rats
63. Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats
64. Differential effects of diet and obesity on high and low affinity sulfonylurea binding sites in the rat brain
65. The role of norepinephrine in adult rat somatosensory (SmI) cortical metabolism and plasticity
66. 3H glyburide binding to brain sulfonylurea receptors in obesity-prone and resistant rats by glucose
67. Defense of body weight against chronic caloric restriction in obesity-prone and resistant rats
68. Dysregulation of arcuate nucleus preproneuropeptide Y mRNA in diet-induced obese rats
69. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats
70. Brain glucosensing and body energy homeostasis; role in obesity and diabetes
71. Brown adipose and metabolic features of chronic diet-induced obesity
72. Gestational obesity accentuates obesity in obesity-prone progeny
73. Reduced glucose-induced neuronal activation in the hypothalamus of diet-induced obese rats
74. Plasticity of brain α-adrenoceptors during the development of diet-induced obesity in the rat
75. 2-adrenoceptors in the arcuate and dorsomedial nucleus
76. Defense of differing body weight set-points in diet-induced obese and resistant rats
77. 2-adrenoceptors in obesity-prone rats
78. Role of the brain in energy balance and obesity
79. Dietary obesity and neonatal sympathectomy. II. Thermoregulation and brown adipose metabolism
80. Differences in saccharin-induced cerebral glucose utilization between obesity-prone and resistant rats
81. Glucose-induced sympathetic activation in obesity-prone and resistant rats
82. Dietary obesity and neonatal sympathectomy I. Effects on body composition and brown adipose
83. Relationship between sympathetic activity and diet-induced obesity in two rat strains
84. Metabolic features of diet-induced obesity without hyperphagia in young rats
85. The effect of diet and chronic obesity on brain catecholamine turnover in the rat
86. Tolerance to anorectic drugs; pharmacological or artifactual
87. Altered hypothalamic function in response to glucose ingestion in obese humans
88. Body composition and adiposity in LH-lesioned and pair-fed obese Zucker rats
89. The spread of the obesity epidemic in the United States, 1991-1998
90. Effect of insulin and insulin-like growth factor I on the expression of the catecholaminergic phenotype by neural crest cells
91. Type II diabetes, essential hypertension, and obesity as 'syndromes of impaired genetic homeostasis'; the 'thrifty genotype' hypothesis enters the 21st century
92. Reduced insulin suppression of glucose appearance is related to susceptibility to dietary obesity in rats
93. Alterations in the offsprings' response to an oral glucose challenge associated with acute maternal malnutrition during late pregnancy
94. Metabolic defects in lean nondiabetic offspring of NIDDM parents; a cross-sectional study
95. Malformations of hypothalamic nuclei in hyperinsulinemic offspring of rats with gestational diabetes
96. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes
97. Overweight and obesity in infants of mothers with long-term insulin-dependent diabetes or gestational diabetes
98. Morphological alterations of hypothalamic nuclei due to intrahypothalamic hyperinsulinemia in newborn rats
99. Hypothalamic insulin and neuropeptide Y in the offspring of gestational diabetic mother rats
100. Increased number of galanin-neurons in the paraventricular hypothalamic nucleus of neonatally overfed weanling rats
101. Perinatal elevation of hypothalamic insulin, acquired malformation of hypothalamic galaninergic neurons, and syndrome X-like alterations in adulthood of neonatally overfed rats
102. Observations on the orexigenic hypothalamic neuropeptide Y-system in neonatally overfed weanling rat
103. Lifelong enhanced diabetes susceptibility and obesity after temporary intrahypothalamic hyperinsulinism during brain organization
104. Obesity and enhanced diabetes and cardiovascular risk in adult rats due to early postnatal overfeeding
105. Reduction of cholecystokinin-8S-neurons in the paraventricular hypothalamic nucleus of neonatally overfed weanling rats
106. Insulin-mediated regulation of neuronal maturation
107. Obesity in young men after famine exposure in utero and early infancy
108. Banting lecture 1988; role of insulin resistance in human disease
109. Decreased ratio of fat to carbohydrate oxidation with increasing age in Pima Indians
110. Prenatal and perinatal influences on long-term psychomotor development in offspring of diabetic mothers
111. Acute fenfluramine administration reduces neuropeptide Y concentrations in specific hypothalamic regions of the rat; possible implications for the anorectic effect of fenfluramine
112. Food deprivation and ingestion induce reciprocal changes in neuropeptide Y-induced feeding in rats
113. Developmental aspect of differences in hypothalamic preproneuropeptide Y messenger ribonucleic acid content in lean and genetically obese Zucker rats
114. Components of hypothalamic obesity; biperidyl-mustard lesions add hyperphagia to monosodium glutamate-induced hyperinsulinemia
115. Impaired glucose tolerance in adolescent offspring of diabetic mothers. relationship to fetal hyperinsulinism
116. Loss of active avoidance responding after lateral hypothalamic injections of 6 hydroxydopamine
117. Neuropepetide Y chronically injected into the hypothalamus; a powerful neurochemical inducer of hyperphagia and obesity
118. Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures
119. Diabetes mellitus preserves synaptic plasticity in hippocampal slices from middle-aged rats
120. Trophic effects of insulin-like growth factor-I on fetal rat hypothalamic cells in culture
121. Persistence of metabolic consequences in the progeny of rats fed a HC formula in their early postnatal life
122. Long-term effects of prenatal stress and handling on metabolic parameters; relationship to corticosterone secretion response
123. On-line monitoring of extracellular brain glucose using microdialysis and a NADPH-linked enzymatic assay
124. Hormonal and metabolic effects of hypothalamic administration of neuropeptide Y during rest and feeding
125. Reduced energy expenditure after ventromedial hypothalamic lesions in female rats
126. Ventromedial hypothalamic lesions abolish compensatory reduction in energy expenditure to weight loss
127. Potential mechanisms of metabolic imprinting that lead to chronic disease
128. Sibutramine in weight control; a dose-ranging, efficacy study
129. Increased neuropeptide-Y messenger ribonucleic acid (mRNA) and decreased neurotensin mRNA in the hypothalamus of the obese (ob/ob) mouse
130. Impaired growth hormone responses to growth hormone-releasing factor in obesity
131. 2-noradrenergic receptors in the rat
132. Reorganization of primary somatosensory cortex and functional recovery from stroke in the adult owl monkey
133. The effect of insulin and insulin-like growth factor-1 on the expression of calretinin and calbindin d-28k in rat embryonic neurons in culture
134. Sympathoadrenal activity in human obesity; heterogeneity of findings since 1980
135. Low ratio of fat to carbohydrate oxidation as predictor of weight gain; study of 24-h RQ